微泡
嗅球
鼻腔给药
间充质干细胞
海马体
神经保护
干细胞
医学
外体
皮质(解剖学)
中枢神经系统
药理学
生物
细胞生物学
神经科学
病理
内科学
小RNA
生物化学
基因
作者
Zihe Zhang,Siqi He,Weijie Jiang,Jing Lu,Songbin Liu,Wenjun Xu,Zhi Wang,Fangfang Lu,Qiguo Xiao,Jia Zhang
出处
期刊:Current Drug Delivery
[Bentham Science]
日期:2024-10-01
卷期号:22
标识
DOI:10.2174/0115672018339798240904171503
摘要
Introduction: Exosomes are nanoscale extracellular vesicles that widely participate in intercellular communication. An increasing number of studies have reported on the neuroprotective effects of stem cell-derived exosomes in brain diseases through various delivery methods. However, only a few reports are available on the delivery and uptake of stem cell-derived exosomes in the brains of mice of different ages. Methods: PKH-26-labelled mesenchymal stem cell-derived exosomes were collected, and their uptake was investigated in the brains of mice aged 2 weeks, 2 months, and >6 months, 24 hours after intranasal delivery. Results: No exosomes were distributed in the whole brains of 2-week-old mice after 24 hours of intranasal delivery. However, a small number of exosomes were found in the olfactory bulb, cortex, and hippocampus of 2-month-old mice, with no exosomes observed in the cerebellum. In contrast, a large number of exosomes were ingested in all brain regions, including the olfactory bulb, cortex, hippocampus, and cerebellum, of >6-month-old mice. Conclusion: Exosomes can enter the brains of adult mice through intranasal administration, but there are differences in the uptake rate among mice of different ages. These findings provide a theoretical basis for the future clinical administration of exosomes for treating brain disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI